Healthcare Sector

Prime Minister Narendra Modi on Sunday said healthcare should be accessible, available and affordable to all and that the Ayushman Bharat scheme is already fulfilling this vision for crores of families across India. In his address after launching projects worth over Rs 2,700 crore here, he said the Central government included Puducherry under the special assistance for capital investment scheme meant only for states. This move benefits the people of the Union territory by way of better infrastructure including better roads. He said: "A strong, empowered youth is the foundation for growth. We are working to support their dreams. At NIT Karaikal, the new Dr APJ Abdul Kalam engineering block and modern hostel facilities will strengthen technical education for many students." Also, he pointed out that infrastructure upgrades have been done in Pondicherry University as well. Furthermore, he said: "When I came here earlier, I had given the mantra of BEST Puducherry. BEST means Business,

Hospital chain reports ₹193.7 crore net profit in Q3 FY26 amid one-time expense; hospital and diagnostics segments post revenue growth and margin expansion

The Maharashtra government signed MoUs worth over ₹10,880 crore for solar, healthcare and manufacturing projects in Vidarbha. It will also roll out new industrial policies soon

Report points to a structural shift in India's $54 billion healthcare market as focused, asset-light providers scale alongside large hospitals

Union Budget 2026 proposes measures across biopharma manufacturing, medical education, research, affordable drugs, AYUSH and medical tourism, signalling a deeper healthcare strategy

Finance Minister Nirmala Sitharaman announced measures in the Union Budget 2026-27 to boost medical tourism, including support for five regional hubs in partnership with states and the private sector

Series A round led by Sorin Investments backs the rollout of minimally invasive, single specialty centres

Australia's spending on health and social care is growing as a share of the economy and now makes up five of the top seven fiscal pressures facing the federal budget

Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus on capturing prescription shares

The surge has come alongside a decline in average issue sizes and more muted listing-day returns compared with last year

Financial services accounted for the largest share of IPO issuance in 2025, reflecting strong issuance from NBFCs, asset managers, insurers and financial platforms during the year

JM Financial has set a target price of ₹1,093 on Fortis Healthcare stock, a potential upside of 22.7 per cent from Friday's closing price

The three-day subscription window to bid for the Gujarat Kidney IPO will close on Wednesday, December 24, 2025

Gujarat Kidney IPO will be offered at a price band of ₹108 to ₹114 per share, with a lot size of 128 shares

The US remains the world's most lucrative outsourcing market, with healthcare spending touching nearly $5 trillion in CY24, accounting for 17-18 per cent of GDP.

Industry says earmarking funds for public health at par with national security will help channel revenue for public health infra

Thyrocare Technologies board had fixed November 28 as the record date for its 2:1 bonus share issue. This smallcap stock has gained 40 per cent in the last two months.

Dr Reddy's Laboratories on Monday said partnerships between policymakers and industry are vital to build a future-ready healthcare system that serves millions. Satish Reddy, the chairman of the Hyderabad-based drug major, joined industry leaders at the sixth Pre-Budget Consultation chaired by Union Finance Minister Nirmala Sitharaman in the national capital. He shared his perspective on the importance of risk-based innovation funding to strengthen India's pharmaceutical ecosystem and accelerate breakthroughs that improve patient access and affordability. "At Dr Reddy's, we believe that partnerships between policymakers and industry are vital to building a future-ready healthcare system that serves millions," Reddy said in a post shared by the drug firm on social networking platform LinkedIn.

JM Financial upgraded the stock to an 'Add' rating after the company reported a 74 per cent jump in its September quarter net profit

The deal marks the Indian hospital chain's entry into the British healthcare market, strengthening its ambition to expand globally